CD22(+)-apoptotic vesicles from cardiac fibroblasts provide endogenous cardioprotection against myocardial ischemia-reperfusion injury.

Zhang C, Hao H, Mu N, Wang Y, Yue Y, Yu L, Ma H

Open source

DOI
10.1007/s11427-025-3251-7
Published
2026 Aug 26
Container
Science China. Life sciences
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11427-025-3251-7,
  title = {CD22(+)-apoptotic vesicles from cardiac fibroblasts provide endogenous cardioprotection against myocardial ischemia-reperfusion injury.},
  author = {Zhang C and Hao H and Mu N and Wang Y and Yue Y and Yu L and Ma H},
  year = {2026},
  journal = {Science China. Life sciences},
  doi = {10.1007/s11427-025-3251-7},
  url = {https://doi.org/10.1007/s11427-025-3251-7}
}

RIS

TY  - JOUR
TI  - CD22(+)-apoptotic vesicles from cardiac fibroblasts provide endogenous cardioprotection against myocardial ischemia-reperfusion injury.
AU  - Zhang C
AU  - Hao H
AU  - Mu N
AU  - Wang Y
AU  - Yue Y
AU  - Yu L
AU  - Ma H
PY  - 2026
JO  - Science China. Life sciences
DO  - 10.1007/s11427-025-3251-7
UR  - https://doi.org/10.1007/s11427-025-3251-7
ER  - 

APA

C, Z., H, H., N, M., Y, W., Y, Y., L, Y., & H, M. (2026). CD22(+)-apoptotic vesicles from cardiac fibroblasts provide endogenous cardioprotection against myocardial ischemia-reperfusion injury.. Science China. Life sciences. https://doi.org/10.1007/s11427-025-3251-7

Source records